unmet needs: sequencing after immunotherapy in nsclc
Published 7 years ago • 440 plays • Length 3:49Download video MP4
Download video MP3
Similar videos
-
1:35
dr. wakelee on unmet needs for immunotherapy in nsclc
-
2:10
unmet needs and role of immunotherapy in stage 3 nsclc
-
1:58
unmet needs in braf nsclc
-
1:49
addressing unmet needs in patients with lung cancer
-
4:51
combining and sequencing immunotherapies in nsclc
-
1:15
dr. gadgeel on unmet needs in patients with cns metastases in nsclc
-
2:26
dr. fred r. hirsch on unmet needs in lung cancer
-
4:24
questions surrounding therapeutic sequencing for nsclc
-
8:22
what to do after progression on immunotherapy and for non-driver nsclc
-
1:00
dr. camidge discusses unmet needs in alk lung cancer
-
5:22
treatment for nsclc after progression on immunotherapy
-
7:34
sequencing checkpoint inhibitors in nsclc
-
6:55
conclusion: addressing unmet needs in lung cancer
-
2:31
the future of lung cancer management: an unmet need in the immuno-oncology era
-
3:46
nsclc stage iii unmet needs and practical advice
-
1:06
dr. wozniak on sequencing immunotherapy in lung cancer
-
1:29
dr. camidge on the unmet needs for lung cancer
-
1:11
dr. lopes on the rationale to stop immunotherapy after 2 years in lung cancer